Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302

2.

Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma.

Choi HJ, Choi YY, Hong SH.

Dis Colon Rectum. 2002 Jun;45(6):750-5; discussion755-6.

PMID:
12072625
3.
4.

Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study.

Adell G, Boeryd B, Frånlund B, Sjödahl R, Håkansson L.

Eur J Surg. 1996 Aug;162(8):637-42.

PMID:
8891622
5.

For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.

Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC.

Cancer. 1998 Aug 15;83(4):666-72.

PMID:
9708929
6.

The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome.

Clarke G, Ryan E, O'Keane JC, Crowe J, MacMathuna P.

Eur J Gastroenterol Hepatol. 2000 May;12(5):549-52.

PMID:
10833099
7.

The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma.

Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M.

J Pathol. 1994 Feb;172(2):183-7.

PMID:
7513353
8.

The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer.

Davies M, Arumugam PJ, Shah VI, Watkins A, Roger Morgan A, Carr ND, Beynon J.

Clin Transl Oncol. 2008 Mar;10(3):175-9.

PMID:
18321821
9.

How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.

Yoshimatsu K, Ishibashi K, Umehara A, Yokomizo H, Yoshida K, Fujimoto T, Watanabe K, Ogawa K.

Hepatogastroenterology. 2005 Nov-Dec;52(66):1703-6.

PMID:
16334761
10.

Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.

Mukai M, Ito I, Mukoyama S, Tajima T, Saito Y, Nakasaki H, Sato S, Makuuchi H.

Oncol Rep. 2003 Jul-Aug;10(4):927-34.

PMID:
12792747
11.

Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer.

Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H, Makuuchi H.

Oncol Rep. 2003 Sep-Oct;10(5):1177-81.

PMID:
12883677
12.
13.

Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer.

Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H, Makuuchi H.

Oncol Rep. 2003 Sep-Oct;10(5):1165-9.

PMID:
12883675
14.

Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.

Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, Bechi P, Cortesini C.

World J Surg. 2002 Mar;26(3):384-9. Epub 2002 Jan 15.

PMID:
11865379
15.
16.

Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma.

García-Sáenz JA, Sáenz MC, González L, Pérez-Segura P, Puente J, López-Tarruella S, Sastre J, Casado A, López-Asenjo JG, Díaz-Rubio E.

Clin Transl Oncol. 2006 Sep;8(9):676-80.

PMID:
17005470
17.

Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study.

Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, Bruch HP, Duchrow M.

Dis Colon Rectum. 1997 Dec;40(12):1465-71.

PMID:
9407986
18.

Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2.

Shimoyama M, Yamazaki T, Suda T, Hatakeyama K.

Dis Colon Rectum. 2003 Mar;46(3):333-9.

PMID:
12626908
19.
20.

Supplemental Content

Support Center